Published in PLoS One on March 09, 2010
Systematic analysis of helical protein interfaces reveals targets for synthetic inhibitors. ACS Chem Biol (2010) 1.29
Structure-based design, synthesis, and characterization of dual hotspot small-molecule HIV-1 entry inhibitors. J Med Chem (2012) 1.29
2P2Idb: a structural database dedicated to orthosteric modulation of protein-protein interactions. Nucleic Acids Res (2012) 1.25
Fine-tuning multiprotein complexes using small molecules. ACS Chem Biol (2012) 1.21
Features of protein-protein interactions that translate into potent inhibitors: topology, surface area and affinity. Expert Rev Mol Med (2012) 1.18
On the binding affinity of macromolecular interactions: daring to ask why proteins interact. J R Soc Interface (2012) 1.16
Using a fragment-based approach to target protein-protein interactions. Chembiochem (2013) 1.09
Plucking the high hanging fruit: a systematic approach for targeting protein-protein interactions. Bioorg Med Chem (2012) 1.03
Small-molecule inhibitor starting points learned from protein-protein interaction inhibitor structure. Bioinformatics (2011) 0.99
Flexibility and small pockets at protein-protein interfaces: New insights into druggability. Prog Biophys Mol Biol (2015) 0.90
Structural basis for LMO2-driven recruitment of the SCL:E47bHLH heterodimer to hematopoietic-specific transcriptional targets. Cell Rep (2013) 0.90
TIMBAL v2: update of a database holding small molecules modulating protein-protein interactions. Database (Oxford) (2013) 0.89
A leap into the chemical space of protein-protein interaction inhibitors. Curr Pharm Des (2012) 0.86
The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth. Oncotarget (2013) 0.86
Structural properties of non-traditional drug targets present new challenges for virtual screening. J Chem Inf Model (2013) 0.83
Targeting protein-protein interactions for parasite control. PLoS One (2011) 0.82
Enhancements to the Rosetta Energy Function Enable Improved Identification of Small Molecules that Inhibit Protein-Protein Interactions. PLoS One (2015) 0.82
Dr. PIAS: an integrative system for assessing the druggability of protein-protein interactions. BMC Bioinformatics (2011) 0.82
Exploring NMR ensembles of calcium binding proteins: perspectives to design inhibitors of protein-protein interactions. BMC Struct Biol (2011) 0.80
Modulating protein-protein interactions with small molecules: the importance of binding hotspots. J Mol Biol (2011) 0.80
Visualisation of variable binding pockets on protein surfaces by probabilistic analysis of related structure sets. BMC Bioinformatics (2012) 0.80
2P2I HUNTER: a tool for filtering orthosteric protein-protein interaction modulators via a dedicated support vector machine. J R Soc Interface (2013) 0.80
HADDOCK(2P2I): a biophysical model for predicting the binding affinity of protein-protein interaction inhibitors. J Chem Inf Model (2014) 0.79
Dr. PIAS 2.0: an update of a database of predicted druggable protein-protein interactions. Database (Oxford) (2012) 0.79
Crystal structure of the human fatty acid synthase enoyl-acyl carrier protein-reductase domain complexed with triclosan reveals allosteric protein-protein interface inhibition. J Biol Chem (2014) 0.79
AlphaSpace: Fragment-Centric Topographical Mapping To Target Protein-Protein Interaction Interfaces. J Chem Inf Model (2015) 0.78
DARC 2.0: Improved Docking and Virtual Screening at Protein Interaction Sites. PLoS One (2015) 0.78
Computational analysis of protein-protein interfaces involving an alpha helix: insights for terphenyl-like molecules binding. BMC Pharmacol Toxicol (2013) 0.78
Structural Disorder within Paramyxoviral Nucleoproteins and Phosphoproteins in Their Free and Bound Forms: From Predictions to Experimental Assessment. Int J Mol Sci (2015) 0.77
Break CDK2/Cyclin E1 interface allosterically with small peptides. PLoS One (2014) 0.77
Computational and biophysical approaches to protein-protein interaction inhibition of Plasmodium falciparum AMA1/RON2 complex. J Comput Aided Mol Des (2015) 0.77
How order and disorder within paramyxoviral nucleoproteins and phosphoproteins orchestrate the molecular interplay of transcription and replication. Cell Mol Life Sci (2017) 0.77
2P2Idb v2: update of a structural database dedicated to orthosteric modulation of protein-protein interactions. Database (Oxford) (2016) 0.76
Computational analysis of C-reactive protein for assessment of molecular dynamics and interaction properties. Cell Biochem Biophys (2013) 0.76
"Solvent hydrogen-bond occlusion": A new model of polar desolvation for biomolecular energetics. J Comput Chem (2017) 0.75
An Intriguing Correlation Based on the Superimposition of Residue Pairs with Inhibitors that Target Protein-Protein Interfaces. Sci Rep (2016) 0.75
Imbalance in chemical space: How to facilitate the identification of protein-protein interaction inhibitors. Sci Rep (2016) 0.75
Principles of protein-protein interactions. Proc Natl Acad Sci U S A (1996) 14.51
How many drug targets are there? Nat Rev Drug Discov (2006) 14.22
Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science (1996) 9.48
Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature (2007) 9.12
X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature (1996) 8.37
Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites. Bioinformatics (2005) 6.82
PDBsum new things. Nucleic Acids Res (2008) 4.55
Structural characterisation and functional significance of transient protein-protein interactions. J Mol Biol (2003) 3.72
Structural basis of IAP recognition by Smac/DIABLO. Nature (2001) 3.66
Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12. Cell (1999) 3.47
Complementarity of structure ensembles in protein-protein binding. Structure (2004) 2.44
Symmetry, form, and shape: guiding principles for robustness in macromolecular machines. Annu Rev Biophys Biomol Struct (2006) 2.24
ProtorP: a protein-protein interaction analysis server. Bioinformatics (2008) 2.09
The X-ray structure of the papillomavirus helicase in complex with its molecular matchmaker E2. Genes Dev (2004) 1.90
Trapping moving targets with small molecules. Science (2009) 1.86
The high-resolution X-ray crystal structure of the complex formed between subtilisin Carlsberg and eglin c, an elastase inhibitor from the leech Hirudo medicinalis. Structural analysis, subtilisin structure and interface geometry. Eur J Biochem (1987) 1.75
Protein-protein interactions as targets for small molecule drug discovery. Biopolymers (2006) 1.68
Inhibition of protein-protein association by small molecules: approaches and progress. J Med Chem (2002) 1.66
Atomic interactions and profile of small molecules disrupting protein-protein interfaces: the TIMBAL database. Chem Biol Drug Des (2009) 1.64
Small-molecule inhibitors of protein-protein interactions. Curr Opin Drug Discov Devel (2008) 1.63
The structure of interleukin-2 complexed with its alpha receptor. Science (2005) 1.53
Predicting druggable binding sites at the protein-protein interface. Drug Discov Today (2008) 1.45
The interface of protein-protein complexes: analysis of contacts and prediction of interactions. Cell Mol Life Sci (2008) 1.41
Emerging classes of protein-protein interaction inhibitors and new tools for their development. Curr Opin Chem Biol (2004) 1.38
DOCKGROUND resource for studying protein-protein interfaces. Bioinformatics (2006) 1.32
Small-molecule inhibitors of the p53-HDM2 interaction for the treatment of cancer. Expert Opin Investig Drugs (2008) 1.28
Solution structure of ZipA, a crucial component of Escherichia coli cell division. Biochemistry (2000) 1.19
Crystal structure of the catalytic domain of matrix metalloproteinase-1 in complex with the inhibitory domain of tissue inhibitor of metalloproteinase-1. J Biol Chem (2006) 1.12
Molecular basis of thrombin recognition by protein C inhibitor revealed by the 1.6-A structure of the heparin-bridged complex. Proc Natl Acad Sci U S A (2008) 0.98
Drug-like inhibitors of protein-protein interactions: a structural examination of effective protein mimicry. Curr Protein Pept Sci (2008) 0.98
Binding, proteolytic, and crystallographic analyses of mutations at the protease-inhibitor interface of the subtilisin BPN'/chymotrypsin inhibitor 2 complex. Biochemistry (2004) 0.98
What induces pocket openings on protein surface patches involved in protein-protein interactions? J Comput Aided Mol Des (2008) 0.97
Peptide segments in protein-protein interfaces. J Biosci (2007) 0.96
A tick protein with a modified Kunitz fold inhibits human tryptase. J Mol Biol (2007) 0.91
Structure and energetics of protein-protein interactions: the role of conformational heterogeneity in OMTKY3 binding to serine proteases. J Mol Biol (2003) 0.86
Global orientation of bound MMP-3 and N-TIMP-1 in solution via residual dipolar couplings. Biochemistry (2003) 0.84
Role of protein flexibility in the design of Bcl-X(L) targeting agents: insight from molecular dynamics. J Comput Aided Mol Des (2008) 0.80
Structural basis of membrane binding by Gla domains of vitamin K-dependent proteins. Nat Struct Biol (2003) 1.68
Structures of three HIV-1 HLA-B*5703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogression. J Immunol (2005) 1.60
Chemical and structural lessons from recent successes in protein-protein interaction inhibition (2P2I). Curr Opin Chem Biol (2011) 1.49
Multiscaled exploration of coupled folding and binding of an intrinsically disordered molecular recognition element in measles virus nucleoprotein. Proc Natl Acad Sci U S A (2013) 1.34
Protein protein interaction inhibition (2P2I) combining high throughput and virtual screening: Application to the HIV-1 Nef protein. Proc Natl Acad Sci U S A (2007) 1.34
Missense mutations in the homeodomain of HOXD13 are associated with brachydactyly types D and E. Am J Hum Genet (2003) 1.29
2P2Idb: a structural database dedicated to orthosteric modulation of protein-protein interactions. Nucleic Acids Res (2012) 1.25
Interaction between the C-terminal domains of N and P proteins of measles virus investigated by NMR. FEBS Lett (2009) 1.00
Impact of geocoding methods on associations between long-term exposure to urban air pollution and lung function. Environ Health Perspect (2013) 0.96
Molecular mapping of the RNA Cap 2'-O-methyltransferase activation interface between severe acute respiratory syndrome coronavirus nsp10 and nsp16. J Biol Chem (2010) 0.93
Structural and genetic analyses reveal a key role in prophage excision for the TorI response regulator inhibitor. J Biol Chem (2005) 0.90
ABCdb: an online resource for ABC transporter repertories from sequenced archaeal and bacterial genomes. FEMS Microbiol Lett (2006) 0.90
Initiation of pre-B cell receptor signaling: common and distinctive features in human and mouse. Semin Immunol (2005) 0.88
Non-nucleoside inhibitors of mitochondrial thymidine kinase (TK-2) differentially inhibit the closely related herpes simplex virus type 1 TK and Drosophila melanogaster multifunctional deoxynucleoside kinase. Mol Pharmacol (2003) 0.87
Identification of allosteric inhibitors blocking the hepatitis C virus polymerase NS5B in the RNA synthesis initiation step. Antiviral Res (2009) 0.87
NMR and MD investigations of human galectin-1/oligosaccharide complexes. Biophys J (2009) 0.85
Symbiotic and taxonomic diversity of rhizobia isolated from Acacia tortilis subsp. raddiana in Africa. Syst Appl Microbiol (2002) 0.85
GFscore: a general nonlinear consensus scoring function for high-throughput docking. J Chem Inf Model (2006) 0.85
Modeling study of human renal chloride channel (hCLC-5) mutations suggests a structural-functional relationship. Kidney Int (2003) 0.83
The cytochrome c3-[Fe]-hydrogenase electron-transfer complex: structural model by NMR restrained docking. FEBS Lett (2003) 0.82
Amplitude of pancreatic lipase lid opening in solution and identification of spin label conformational subensembles by combining continuous wave and pulsed EPR spectroscopy and molecular dynamics. Biochemistry (2010) 0.82
Modified cap group suberoylanilide hydroxamic acid histone deacetylase inhibitor derivatives reveal improved selective antileukemic activity. J Med Chem (2010) 0.82
The type I/type II cytochrome c3 complex: an electron transfer link in the hydrogen-sulfate reduction pathway. J Mol Biol (2005) 0.82
Prevalence, specificity and determinants of lipid-interacting PDZ domains from an in-cell screen and in vitro binding experiments. PLoS One (2013) 0.81
A specific protein disorder catalyzer of HIV-1 Nef. Bioorg Med Chem (2011) 0.81
Multiple orientations in a physiological complex: the pyruvate-ferredoxin oxidoreductase-ferredoxin system. Biochemistry (2004) 0.81
Identification and biophysical assessment of the molecular recognition mechanisms between the human haemopoietic cell kinase Src homology domain 3 and ALG-2-interacting protein X. Biochem J (2010) 0.81
Computational studies of human galectin-1: role of conserved tryptophan residue in stacking interaction with carbohydrate ligands. J Biomol Struct Dyn (2009) 0.80
Protein-protein interaction inhibition (2P2I): fewer and fewer undruggable targets. Comb Chem High Throughput Screen (2009) 0.80
2P2I HUNTER: a tool for filtering orthosteric protein-protein interaction modulators via a dedicated support vector machine. J R Soc Interface (2013) 0.80
The crystal structure of the hexadeca-heme cytochrome Hmc and a structural model of its complex with cytochrome c(3). Structure (2002) 0.79
An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity. Bioorg Med Chem (2010) 0.79
Focused chemical libraries--design and enrichment: an example of protein-protein interaction chemical space. Future Med Chem (2014) 0.79
TM0486 from the hyperthermophilic anaerobe Thermotoga maritima is a thiamin-binding protein involved in response of the cell to oxidative conditions. J Mol Biol (2010) 0.78
Structural recognition mechanisms between human Src homology domain 3 (SH3) and ALG-2-interacting protein X (Alix). FEBS Lett (2012) 0.78
Reply to Jensen and Blackledge: Dual quantifications of intrinsically disordered proteins by NMR ensembles and molecular dynamics simulations. Proc Natl Acad Sci U S A (2014) 0.78
A peptide mimic of an antigenic loop of alpha-human chorionic gonadotropin hormone: solution structure and interaction with a llama V(HH) domain. Biochem J (2002) 0.78
Structural basis for galectin-1-dependent pre-B cell receptor (pre-BCR) activation. J Biol Chem (2012) 0.77
Solution structure of HndAc: a thioredoxin-like domain involved in the NADP-reducing hydrogenase complex. Protein Sci (2006) 0.75
MEMO associated with an ErbB2 receptor phosphopeptide reveals a new phosphotyrosine motif. FEBS Lett (2011) 0.75
Sequential NMR assignment of the ferri-cytochrome c3 from Desulfovibrio vulgaris Hildenborough. J Biomol NMR (2002) 0.75
Stereoselective synthesis of original spirolactams displaying promising folded structures. Org Biomol Chem (2013) 0.75
Aminoacylase 1-catalysed deacetylation of bioactives epoxides mycotoxin-derived mercapturates; 3,4-epoxyprecocenes as models of cytotoxic epoxides. Biochimie (2012) 0.75